| Ytd | 21.41% | |
| 1y | -44.78% |
| Open | 8.24 | Prev Close | 8.90 | Low | 7.82 | High | 8.90 | Mkt Cap | 9.63M |
| Vol | 1.19M | Avg Vol | 156.26K | EPS | -0.11 | P/E | -80.91 | Forward P/E | N/A |
| Beta | 0.52 | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-15 | 50-d Avg | 4.75 | 200-d Avg | 6.17 | 1yr Est | 0.00 |
ADVB News
Advanced Biomed stock surges after withdrawing its SEC Form S-1, removing a planned securities offer
Gainers Zhengye Biotechnology (NASDAQ:ZYBT) shares increased by 322.6% to $2.95 during Monday's
U.S. stocks traded mixed midway through trading, with the Dow Jones index falling over 100 points on
US stocks higher, Nasdaq up 1% as Dow rises 0.25%. Domino's Pizza stock increases 4% on revenue
Gainers Advanced Biomed (NASDAQ:ADVB) shares rose 24.1% to $6.24 during Monday's pre-market ses
Eva Live gained 16.4% in pre-market trading after signing a letter of intent to acquire Airbeam Wire
Gainers iTonic Holdings (NASDAQ:ITOC) stock increased by 8.1% to $0.3 during Friday's after-mar
Gainers Alzamend Neuro (NASDAQ:ALZN) stock increased by 12.9% to $1.35 during Tuesday's after-m
Advanced Biomed (NASDAQ:ADVB) reported quarterly losses of $(0.38) per share. This is a 67.52 percen
eBay (NASDAQ: EBAY) rose sharply after GameStop (NYSE: GME) proposed to acquire it for $125/share, v
SILO stock rose 51.8% in pre-market trading after its PTSD treatment pipeline received a patent from
Tainan City, Taiwan, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Advanced Biomed Inc. (Nasdaq: ADVB) (the “Com
Tainan, Taiwan, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Advanced Biomed Inc. (Nasdaq: ADVB) (the “Company”
Tainan City, Taiwan, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Advanced Biomed Inc. (Nasdaq: ADVB) (the “Com
Gainers Enanta Pharma (NASDAQ: ENTA) stock rose 15.6% to $9.13 during Friday's after-market ses
[Tainan City], Taiwan, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Advanced Biomed Inc. (Nasdaq: ADVB) (the “
Tainan, Taiwan, March 07, 2025 (GLOBE NEWSWIRE) -- Advanced Biomed Inc. (the "Company") (NASDAQ: ADV
Advanced Biomed has filed proposed terms for a $112 million U.S. IPO. The firm is developing a portf
Advanced Biomed Inc. ADVB, has set terms for its initial public offering, in which the Taiwan-based
Advanced Biomed has filed to raise $150 million in a U.S. IPO, although the final amount may vary. T
Advanced Biomed, a Taiwan-based diagnostics developer, is planning to raise up to $150 million in an